The resistance of pathogens to commonly used antibiotics has enhanced morbidity and mortality and has triggered the search for new drugs. Several species of the red alga genus Laurencia are very interesting candidates as potential sources of natural products with pharmaceutical activity because they are known to produce a wide range of chemically interesting halogenated secondary metabolites. This is an initial report of the antifungal activities of the secondary metabolites of five species of Laurencia, collected in the state of Espírito Santo, against three strains of pathogenic fungi: Candida albicans (CA), Candida parapsilosis (CP), and Cryptococcus neoformans (CN). Minimum inhibitory concentrations (MIC) of the algal extracts were determined by serial dilution method in RPMI 1640 Medium in 96-well plates according to the NCCLS and microbial growth was determined by absorbance at 492nm. A result showing maintenance or reduction of the inoculum was defined as fungistatic, while fungicidal action was no observed growth in the 10 µL fungistatic samples subcultured in Sabouraud Agar. Our results indicate that apolar extracts of Laurencia species possess antifungal properties and encourage continued research to find new drugs for therapy of infectious diseases in these algae.
Introduction
Currently, multiple drug resistance of human pathogenic microorganisms is due to the indiscriminate use of the commercial antimicrobials commonly used for the treatment of infectious diseases (Karaman et al., 2003) . The search for new, more specific and better adapted antimicrobial agents has been further stimulated by the occurrence of fatal opportunistic infections associated with AIDS, antineoplasic chemotherapy and transplants (Penna et al., 2001) .
As a consequence of the increasing demand for biodiversity in screening programs for potential therapeutic activities of natural products, there is an increased interest in marine fauna and flora throughout the world (Sasidharan et al., 2010) . In this context, tropical marine algae have proven to be a rich source of bioactive compounds of potential biomedicinal interest (Sieburth, 1964; Burkholder, 1973; Caccamese et al., 1981; Reichelt & Borowitzka, 1984; Robles-Centeno et al., 1996; Plaza et al., 2010) .
Brazil occupies a prominent position as an interesting source of natural products due to the richness of its biodiversity, including the red seaweed genus Laurencia (Fujii & Sentíes, 2005) , which is known to produce numerous biologically active halogenated secondary metabolites with a diversity of structural features (Erickson, 1983) , predominantly sesquiterpenes, diterpenes, and acetylenes (Blunt et al., 2005) . Many of these metabolites have been isolated and their structures determined, but their biological activity needs to be investigated in more detail (Ireland et al., 2000) .
There are numerous studies testing inhibition against bacteria, some viruses and marine fungi, but there are few studies of the activity of compounds or extracts of Laurencia against human pathogenic fungi. Ballantine et al. (1987) collected Laurencia obtusa (Huds.) J.V. Lamour., Yuzurua poiteaui (J.V. Lamour.) Martin-Lescanne (as Laurencia poitei) and Laurencia sp. from Puerto Rico and evaluated the antifungal properties of chloroform/ methanol (2:1) extracts against Candida albicans. The L. obtusa extract showed a 0.5 mm inhibition using the disc-agar method.
Most authors use agar diffusion assays to determine the antimicrobial activity of algal extracts. The technique works adequately with well-defined inhibitors (Hewitt & Vincent, 1989) , but with extracts that contain unknown components there are problems with false positive and false negative results (Eloff, 1998) . The type of agar, the salt concentration, the incubation temperature, and the molecular size of the antimicrobial components can all influence the results obtained with agar diffusion assays (Marsh & Goode, 1994) . Furthermore, this technique also cannot distinguish between fungicidal (the lowest concentration of the agent that results in no growth) and fungistatic (the lowest concentration of the agent that results in the maintenance or reduction of the inoculum) effects (Hammer et al., 2003) and does not permit determination of the minimum inhibitory concentration (MIC) (Eloff, 1998) .
The present study is an initial report of the results of screening assays for a variety of biological activities with extracts of Laurencia species, with the aim of identifying novel and interesting potentially useful therapeutic activities. In this paper, we describe the antifungal activities of extracts of five Laurencia species collected in the state of Espírito Santo, Southeastern Brazil, measured by using a sensitive and rapid serial dilution technique in 96-well microplates. After collection, the fresh algae were washed thoroughly with seawater, followed by fresh water to remove sand particles and epiphytes. The cleaned material was stored frozen at -20 o C until preparation of the extracts. For that purpose, approximately 30 g of dried and powdered alga was added to 300 mL of hexane and allowed to soak overnight. To ensure complete extraction, this procedure was repeated on three subsequent days. The extract was filtered and concentrated on a rotary evaporator. The same procedure was repeated using chloroform, methanol and water, generating the hexane, chloroform, methanol and aqueous extracts. In addition, a crude water extract was prepared from 30 g of fresh alga in water to obtain a clean, non-toxic extract preparation that was then concentrated on a Speed Vac. The dried extracts were re-dissolved in 10% ethanol (by volume) or water to yield a solution containing 4 mg of extract per mL of growth medium.
Materials and Methods

Algae and preparation of the extracts
Microorganisms
The test organisms included three American Type Culture Collection (ATCC) fungal strains: Candida albicans ATCC 10231 (CA), Candida parapsilosis ATCC 29212 (CP) and Cryptococcus neoformans ATCC 90112 (CN).
Antifungal Drug and microdilution tray
Fluconazole was obtained as a reagent-grade powder from Sigma. Microdilution trays containing serial dilutions of the antifungal agent in RPMI 1640 medium (Sigma) were prepared in a single lot and stored frozen at -20 °C until used in the study.
Broth microdilution assay
Broth microdilution assays were performed according to National Committee for Clinical Laboratory Standards (NCCLS) for the establishment of quality control and referenced strain, using the methods (NCCLS, 2002) with minor modifications.
Yeast inocula were prepared by growing isolates on Sabouraud dextrose agar (SDA) for 24-48 h at 35 °C and then suspending growth in 5 mL of saline (0.145 mol.L -1 ) prepared in sterile distilled water. The optical density of this suspension was adjusted to 0.5 McFarland standard turbidity in a Shimadzu UV-1650 PC spectrophotometer (Kyoto, Japan) to obtain a concentration of 1 x 10 6 to 5 x 10 6 UFC.mL -1 and then diluted 1:100 followed by 1:20 in RPMI 1640 medium to obtain a final inoculum concentration of 5.0 x 10 2 to 2.5 x 10 3 UFC.mL -1 . Serial dilutions were prepared in 96-well microplates with 50 µL of RPMI 1640 Medium in each well as described (Zgoda & Porter, 2001 ) with the following modifications. A 50 µL aliquot of initially prepared extract at the concentration of 4mg/ml was added into the first well. Then, 50 µL aliquots of the corresponding serial dilutions were transferred into six consecutive wells to obtain final concentrations ranging from 1,000 to 31.25 μg.mL -1 (50 µL). The last well contained just 50 µL of nutrient broth plus an aliquot of the extract vehicle (10% ethanol or water), used as the negative control. After serial dilution, 50 µL of the inoculum were added to the wells. Of the known algal secondary metabolites with biological activities, approximately 90% are lipidsoluble (Norris & Fenical, 1985) . The survey reported here was undertaken to assess the occurrence of lipidsoluble bioactive materials in these macroalgal species and to evaluate them more thoroughly as sources of potentially useful bioactive substances.
The present technique using 96-well microplates and spectrophotometric detection of the MIC was successfully applied to compare the antifungal activities of extracts from different species of Laurencia. The method is robust, inexpensive, relatively quick and 30-fold more sensitive than other methods commonly used in the literature; in addition, it requires only a small quantity of sample, can be applied to a large number of samples (very useful for screening), and provides a permanent record of the results (Ellof, 1998) .
The importance of investigating the activity of crude extracts lies in identifying promising candidates for additional investigation. In addition, the activity of in each well was 100 µL. Fluconazole was prepared in water at concentrations ranging from 64 to 2 μg.m L-1 and used as the standard for the positive control.
Spectrophotometric determination of the Minimum Inhibitory Concentration (MIC)
For yeasts, the MIC value was determined as the lowest concentration of the extract in the broth medium that resulted in maintenance or reduction of the inoculum (Hammer et al., 2003) . Spectrophotometric readings on each well were performed with a Tecan M200 automated plate reader (Männedorf, Switzerland) set at 492 nm after the well had been agitated. MIC endpoints were determined as the first concentration of the antifungal agent at which turbidity in the well was ≥50% less than that in the control well (Pfaller et al., 1995) .
Determination of Concentration Effects (CE)
The concentration effects were determined by subculturing 10 µL from each well of the microtiter tray that showed inhibition, carried out by spot inoculating onto SDA and incubating aerobically at 35 °C. Any inoculum growth on agar plates corresponds to a fungistatic effect, while a fungicidal effect is characterized by no observed growth of the 10 µL fungistatic samples subcultured in Sabouraud Agar (Hammer et al, 2003) .
Statistical analysis
The extract fractions were prepared in triplicate and measured for their antifungal activity, expressed as the percentage of activity (%AE) with the formula adapted from Felício et al. (2008) :
Where AE represents the "absorbance of the test plates after the incubation time"; AEB is the "absorbance of plates containing medium, sample and inoculum at t=0 of incubation"; AC is the "absorbance of plates containing negative control (with or without vehicle) (100% of inoculum growth)"; and ACB is the "absorbance of plates containing culture medium". All of the MIC values were calculated by nonlinear regression.
Results and discussion
The data obtained by the microdilution technique are collected in Table 2 . The MIC of the % AE = 100 -AE -AEB AC -ACB x 100
Screening for antifungal activities of extracts of the Brazilian seaweed genus Laurencia (Ceramiales, Rhodophyta) Erika M. Stein et al. an extract may be due synergy between two or more components and other beneficial pharmacological or medicinal properties can be explored. For extracts that show activity, subsequent fractionation or isolation of the individual components is necessary to obtain an understanding of the activity of each individual component and of the contribution of each component to the overall activity of the extract as a whole. In conclusion, this study suggests that apolar extracts of several species of Laurencia possess interesting antifungal properties, which should encorage the continued search for new drugs for therapy of infectious diseases derived from marine algae. 
